Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | RAB9A | P51151 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 6/20 | 1.00 |
| ▸ | HPGD | P15428 | 6/20 | 1.00 |
| ▸ | NPC1 | O15118 | 6/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | HSD17B2 | P37059 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 3/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | MAOA | P21397 | 3/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Genistein SCHEMBL554056 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL29352944 | 1.00 | MAPT (1.00) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL31168045 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL551402 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL551801 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL551449 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL29586842 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL551352 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL38650814 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 | |
| Genistein SCHEMBL29586487 | 0.98 | MAPT (0.97) | MAPTSMN1; SMN2ALDH1A1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 51116 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075533-A | S-equol composition for delaying ovarian aging and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12636311-B2 | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation | GALLEON LABS LLC (US) | 2026-05-26 | — | — | US | claimed |
| CN-122081128-A | Lactobacillus rhamnosus and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026107510-A1 | HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION | BIOBOND ADHESIVES, INC. (US) | 2026-05-21 | — | — | WO | claimed |
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| CN-122056884-A | Methods of treating pancreatic cancer | 坎莫森特里克斯公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122031592-A | Application of dragon's blood and active ingredients thereof in preparation of drugs for treating heart failure | 上海中医药大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122033259-A | Preparation method of low-dimensional silver nanostructure driven by dynamic polymer hydrogel | 深圳市源利电子新材料有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026099270-A1 | BIODEGRADABLE UV ABSORBERS AND USES THEREOF II | BASF SE (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260130395-A1 | Water Dispersible Botanical Compositions | AQUILA BLACK LTD (AU) | 2026-05-14 | — | — | US | claimed |
| US-5352384-A | Aglucone isoflavone enriched vegetable protein fiber | PROTEIN TECHNOLOGIES INTERNATIONAL, INC. (US) | 1994-10-04 | — | — | US | claimed |
| EP-0595133-A2 | Prodrugs, their preparation and use as medicaments | BEHRINGWERKE Aktiengesellschaft (DE) | 1994-05-04 | — | — | EP | claimed |
| WO-1993023069-A1 | HEALTH SUPPLEMENTS CONTAINING PHYTO-OESTROGENS, ANALOGUES OR METABOLITES THEREOF | KELLY GRAHAM EDMUND (AU) | 1993-11-25 | — | — | WO | claimed |
| EP-0273771-B1 | MUTAGENIC EVALUATION METHOD | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-22 | — | — | EP | claimed |
| US-5229113-A | Gene expression, soybeans | LUBRIZOL GENETICS, INC. (US) | 1993-07-20 | — | — | US | claimed |
| US-5213971-A | Process for inducing cytochrome P-450 enzymes in Streptomyces bacteria and determining the mutagenicity of chemicals | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-05-25 | — | — | US | claimed |
| EP-0269725-A4 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE. | LUBRIZOL GENETICS INC (US) | 1989-01-12 | — | — | EP | claimed |
| EP-0273771-A2 | Mutagenic evaluation method | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-07-06 | — | — | EP | claimed |
| EP-0269725-A1 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE | LUBRIZOL GENETICS INC. (US) | 1988-06-08 | — | — | EP | claimed |
| WO-1987007910-A1 | BRADYRHIZOBIUM JAPONICUM NODULATION REGULATORY PROTEIN AND GENE | LUBRIZOL GENETICS, INC. (US) | 1987-12-30 | — | — | WO | claimed |